Scott Young | VP Corporate Communications and IR |
Mike Clayman | CEO and Co-Founder |
David Arkowitz | CFO |
Bryan Rolfe | BMO Capital Markets |
Elliot Wilbur | Raymond James |
Patrick Trucchio | Berenberg Capital Markets |
Serge Belanger | Needham & Company |
Francois Brisebois | Laidlaw |
* |
Good afternoon, ladies and gentlemen and welcome to the Flexion Therapeutics Second Quarter 2019 Financial Results Conference Call. My name is Brian and I will be your coordinator today. At this time, all participants are in a listen-only mode. [Operator Instructions]
I'll now turn the call over to the Company.